Treatment of neurological or neurodegenerative disorders

摘要

Use of a protein or peptide for the manufacture of a medicament for the treatment of neurological or neurodegenerative disorders, in particular stroke, wherein the protein or peptide is selected form the group consisting of a kringle protein or peptide comprising or consisting of amino acid sequences which are derived from the plasminogen activator-related kringle (PARK) domain or desmoteplase activator-related (DARK) domain.